Generic

September 26, 2019

How Labour’s UK generic drugs plan could have been better

Companies and investors have not completely dismissed the UK Labour party’s proposals for cheaper drugs – but some ideas have proven more equal than others.

Price fixing case caps a terrible week for generics

Shares in generics firms tumble in the wake of a huge lawsuit in the US alleging industry-wide price fixing, signalling many more years of pain for this sector.

September 07, 2018

Civica Rx goes where generics companies fear to tread

A non-profit partnership of 500 hospitals wants to deliver its first generic drugs in 2019, lowering prices and stabilising supplies.

May 15, 2018

Pfenex readies to swim upstream with Forteo copycat

May 03, 2018

Biosimilar knockbacks expose increasing big pharma focus

April 17, 2018

Private equity cleans up Sanofi’s failed generics foray

February 20, 2018

Interview – Rani’s pill injector promises much, but is still preclinical

January 24, 2018

Novartis investors put faith in new chief

December 14, 2017

Teva investors applaud and staff revolt, as Schultz swings the axe

October 04, 2017

A determined FDA takes down Teva’s blockbuster

Earlier-than-expected US approval for Mylan's generic version of Teva's Copaxone is a blow to the struggling Israeli firm.

September 28, 2017

Abbvie sets the date for cash cow slaughter

Load More